Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vyvgart
Pharma
Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial
Shortly after teeing up Vyvgart Hytrulo for entry into another potential immunology niche, argenx has stumbled against a separate target.
Fraiser Kansteiner
Oct 8, 2026 10:44am
Argenx preps next potential Vyvgart nod after ph. 3 win
Aug 17, 2026 10:52am
J&J data set up Imaavy for expansion to treat anemic disorder
Jun 11, 2026 10:36am
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am
Argenx's Vyvgart posts ph. 3 win in ocular myasthenia gravis
Feb 26, 2026 11:18am
FDA untitled letters target drug ads from Novo, argenx, Sobi
Feb 10, 2026 11:42am
